| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/24/2008 | CN101328284A Cellulose, composition of derivate thereof, and use in pharmacy industry |
| 12/24/2008 | CN101328213A G-CSF conjugates |
| 12/24/2008 | CN101327328A Dendrimers targeting nano particle and preparation and application thereof |
| 12/24/2008 | CN101327327A PEGylated recombined Aspergillus flavus uricoxidase coupling compound and preparation technique |
| 12/24/2008 | CN101327326A Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility |
| 12/24/2008 | CN101327320A Enzyme treatment for infection |
| 12/24/2008 | CN101327311A Zedoary turmeric oil buccal tablets |
| 12/24/2008 | CN101327296A Compound Chinese medicine preparation for treating and improving insomnia and preparation method thereof |
| 12/24/2008 | CN101327286A Pain-relieving anti-inflammation medicament and preparation method thereof and use |
| 12/24/2008 | CN101327279A Medicament for treating skin disease and preparation thereof |
| 12/24/2008 | CN101327262A Qingkailing suppositorium |
| 12/24/2008 | CN101327252A Decumbent corydalis tuber in situ forming eye gel |
| 12/24/2008 | CN101327222A Bear's gall in situ forming eye gel |
| 12/24/2008 | CN101327219A Prednisolone acetate in situ forming eye gel |
| 12/24/2008 | CN101327216A Atropine sulfate in situ forming eye gel |
| 12/24/2008 | CN101327213A Irbesartan and hydrochlorothiazide pharmaceutical composition and preparation method thereof |
| 12/24/2008 | CN101327206A Docetaxel injection and preparation method thereof |
| 12/24/2008 | CN101327202A Vitamin K1 lyophilized powder for injection and preparation method |
| 12/24/2008 | CN101327201A Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 12/24/2008 | CN101327195A Losartan potassium and hydrochlorothiazide tablets and preparation method thereof |
| 12/24/2008 | CN101327194A Hydrochloric acid diltiazem freeze-dried powder injection for injections and preparation method thereof |
| 12/24/2008 | CN101327193A Lornoxicam freeze-dried injection and preparation method thereof |
| 12/24/2008 | CN101327192A Fleraxacin for injection and preparation method thereof |
| 12/24/2008 | CN101327190A Anti-tumor long-circulating target liposomes for injections |
| 12/24/2008 | CN101327189A Method for preparing nano alcohol liposome material with mark and treatment double-function |
| 12/24/2008 | CN101327188A Bisphosphonates microemulsion and preparation method thereof |
| 12/24/2008 | CN101327187A Nonoxynol nonylphenoxy-polyethoxyethanol suppositorium and preparation method thereof |
| 12/24/2008 | CN101327186A Anticancer implantation agent |
| 12/24/2008 | CN101327184A Solid preparation containing diphenhydramine |
| 12/24/2008 | CN101327183A Method for preparing chitosan in situ gel agent |
| 12/24/2008 | CN101327182A Preparation of nano crystal fibre felt of water-insoluble medicament |
| 12/24/2008 | CN101327181A Puerarin in situ forming eye gel |
| 12/24/2008 | CN100444898C Novel glp-1 derivatives |
| 12/24/2008 | CN100444897C Nano complex eye drops containing liposoluble compound drug and its preparing method |
| 12/24/2008 | CN100444896C Chitin nanometer granule for programmable releasing various kinds of medicine, and its prepn. method |
| 12/24/2008 | CN100444848C Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 12/24/2008 | CN100444833C Oral dosage form for controlled drug release |
| 12/24/2008 | CN100444830C Multiparticulate modified release composition |
| 12/24/2008 | CN100444828C Preparation method of biodegradable polymer pharmaceutical microsphere |
| 12/24/2008 | CA2691443A1 Phenyl ester side chains to increase polymer resorptivity |
| 12/24/2008 | CA2689524A1 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x |
| 12/23/2008 | US7468418 Compositions for enhancing transport of molecules into cells |
| 12/23/2008 | US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468354 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 12/23/2008 | US7468352 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/23/2008 | US7468351 Erythropoietin solution formulation |
| 12/23/2008 | US7468350 Glue composition for lung volume reduction |
| 12/23/2008 | US7468193 Nutritional composition against side effects of chemotherapy or radiotherapy |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | US7468172 Hydroxapatite calcium phosphates, their methods of preparation and their applications |
| 12/23/2008 | CA2426074C Inhalable formulation of a solution containing a tiotropium salt |
| 12/23/2008 | CA2419993C Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 12/23/2008 | CA2419067C Injectable composition comprising benzimidazole compound and strong alkali |
| 12/23/2008 | CA2387370C Percutaneous sorbefacients for electroporation |
| 12/23/2008 | CA2379003C Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides |
| 12/23/2008 | CA2372339C Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction |
| 12/23/2008 | CA2371321C Novel high viscosity embolizing compositions |
| 12/23/2008 | CA2339978C Process for obtaining highly-purified alginates |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2326456C Composition and method of preparing microparticles of water-insoluble substances |
| 12/23/2008 | CA2319810C Propofol composition containing sulfite |
| 12/23/2008 | CA2260185C Hormone replacement therapy drug formulations for topical application to the skin |
| 12/23/2008 | CA2249320C Glycosylated humanized b-cell specific antibodies |
| 12/23/2008 | CA2246397C Solid and semi-solid hydrocarbon gels and uses thereof |
| 12/23/2008 | CA2178594C Absorption enhancers for topical pharmaceutical formulations |
| 12/23/2008 | CA2175966C Antibacterial oral gel composition for application to dental implant areas |
| 12/23/2008 | CA2100925C Process for preparing microspheres for the prolonged release of the lhrh hormone and its analogues, microspheres and formulations obtained |
| 12/21/2008 | CA2635407A1 An ectoparasiticide composition and a method for exterminating ectoparasites |
| 12/18/2008 | WO2008154294A1 Method and composition for providing controlled delivery of biologically active substances |
| 12/18/2008 | WO2008154178A1 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 12/18/2008 | WO2008153746A1 Formulations and methods for treating dry eye |
| 12/18/2008 | WO2008153744A2 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 12/18/2008 | WO2008153611A2 Sustained delivery formulations of risperidone compounds |
| 12/18/2008 | WO2008153582A1 Concentrate esmolol |
| 12/18/2008 | WO2008153077A1 Anti-norovirus agent, and composition comprising the same |
| 12/18/2008 | WO2008153035A1 Liposome preparation for iontophoresis comprising insulin enclosed therein |
| 12/18/2008 | WO2008152764A1 Pharmaceutical composition |
| 12/18/2008 | WO2008152729A1 Jelly-like pharmaceutical composition containing risperidone |
| 12/18/2008 | WO2008152669A2 Colloidal vectors with polyaminoacid structure for oral release of peptides and proteins and method for their production |
| 12/18/2008 | WO2008152401A1 Peptide slow-release formulations |
| 12/18/2008 | WO2008152262A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 12/18/2008 | WO2008152226A2 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof |
| 12/18/2008 | WO2008152140A2 Recombinant transferrin mutants |
| 12/18/2008 | WO2008152106A1 Pharmaceutical formulation comprising an insulin derivative |
| 12/18/2008 | WO2008151512A1 Site-specific pegylated linear salmon calcitonin derivatives |
| 12/18/2008 | WO2008151433A1 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | WO2008129318A3 A foam material for medical use and method for producing same |
| 12/18/2008 | WO2008125239A3 Dry extracts of pelargonium sidoides and pelargonium reniforme |
| 12/18/2008 | WO2008120548A3 Oral disintegrating tablet |
| 12/18/2008 | WO2008112286A9 De novo synthesis of conjugates |
| 12/18/2008 | WO2008099068B1 Liquid anhydrous composition to be incorporated into the drinking water of cattle |
| 12/18/2008 | WO2008037484A3 Formulations comprising cyclic compounds |
| 12/18/2008 | WO2008021666A3 Stable liquid levetiracetam compositions and methods |
| 12/18/2008 | WO2007087341A3 Tolerogenic biodegradable artificial antigen presenting system |
| 12/18/2008 | WO2003024455A8 Stent coated with a sustained-release drug delivery and method for use thereof |
| 12/18/2008 | US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/18/2008 | US20080312407 Glycopeptide phosphonate derivatives |
| 12/18/2008 | US20080312345 Aqueous Film Coating Composition Containing Sodium Alginate and Preparation Thereof |
| 12/18/2008 | US20080312344 Dendrimers multivalently substituted with active groups |